Related Experiment Video
Updated: Jul 11, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3
Lena Thyrell1, Velmurugesan Arulampalam, Linn Hjortsberg
1Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Hospital and Institute, S-171 76 Stockholm, Sweden.
Abstract:
In multiple myeloma, which commonly depends on interleukin 6, IL-6, survival signaling induced by this cytokine is largely mediated by activation of STAT3. Interferon alpha (IFNalpha) treatment of cell lines derived from multiple myeloma or of myeloma tumor cells ex vivo leads to apoptosis. In this study we demonstrate that IFNalpha treatment of the two myeloma cell lines, U266-1984 and U-1958, results in the decrease of STAT3 activity as demonstrated by a diminished STAT3/3 DNA-binding activity and the shift from STAT3/3 towards STAT1/1 and STAT3/1 complexes in EMSA, leading to the down-regulation of known STAT3 target genes such as Bcl-X(L), Mcl-1 and survivin. Ectopic expression of a form of STAT3, STAT3C, rescued U266-1984 cells from IFNalpha-induced apoptosis. IFNalpha promoted sustained accumulation of tyrosine phosphorylated STAT3C in the nucleus and a prolonged DNA binding of the STAT3/3 homodimers in EMSA. The shift towards a sustained STAT3 response in IFNalpha-treated STAT3C-transfected cells led to a hyper-induction of Bcl-2 and Mcl-1 proteins. Thus our data demonstrated that IFNalpha is able to interfere with IL-6 signaling by inhibiting STAT3 activity and that the abrogation of STAT3 activity accounts for the ability of IFNalpha to induce apoptosis in myeloma cells.
Insights
Interferon alpha (IFNalpha) inhibits STAT3 signaling, a key survival pathway in multiple myeloma. This inhibition leads to apoptosis in myeloma cells, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Multiple myeloma survival often relies on interleukin 6 (IL-6) signaling.
- IL-6 survival signaling is primarily mediated by Signal Transducer and Activator of Transcription 3 (STAT3) activation.
- Interferon alpha (IFNalpha) induces apoptosis in multiple myeloma cells.
Purpose of the Study:
- To investigate the mechanism by which IFNalpha induces apoptosis in multiple myeloma cells.
- To determine the role of STAT3 signaling in IFNalpha-mediated apoptosis.
- To explore the interaction between IFNalpha and IL-6/STAT3 pathways in myeloma.
Main Methods:
- Treatment of multiple myeloma cell lines (U266-1984, U-1958) with IFNalpha.
- Electrophoretic Mobility Shift Assay (EMSA) to assess STAT3 DNA-binding activity.
- Analysis of STAT3 target gene expression (Bcl-X(L), Mcl-1, survivin).
- Ectopic expression of a constitutively active STAT3 mutant (STAT3C).
Main Results:
- IFNalpha treatment decreased STAT3 DNA-binding activity and shifted STAT complexes from STAT3/3 to STAT1/1 and STAT3/1.
- This led to down-regulation of STAT3 target genes like Bcl-X(L), Mcl-1, and survivin.
- Ectopic expression of STAT3C rescued cells from IFNalpha-induced apoptosis, promoting sustained STAT3 activity and up-regulation of Bcl-2 and Mcl-1.
Conclusions:
- IFNalpha interferes with IL-6 signaling by inhibiting STAT3 activity in multiple myeloma cells.
- The abrogation of STAT3 activity by IFNalpha is crucial for inducing apoptosis in myeloma.
- Targeting STAT3 signaling with IFNalpha presents a potential therapeutic approach for multiple myeloma.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
The JAK-STAT Signaling Pathway
The Extrinsic Apoptotic Pathway
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IlI: Cellular Death

